|

U-M study sheds light on how bacteria control their detoxification

By Morgan Sherburne, Michigan News

Bacteria need to constantly adapt to compete against other species for nutrient sources and to survive against threats such as antibiotics and toxins. In an effort to understand how bacteria control and regulate this adaptation, University of Michigan researchers from the Center for RNA Biomedicine are examining how RNA polymerase—the enzyme that transcribes genetic information from DNA onto RNA—slows during transcription in a process called transcriptional pausing.

They found that a protein called N-utilizing substance A, or NusA, in concert with another control element called a riboswitch, fine-tunes the transcription speed in order to regulate gene expression. Gene expression is the process by which genetic information is converted into the building blocks of the bacterium.

The researchers say their work, published in the Proceedings of the National Academy of Sciences, expands our general understanding of the transcription process in bacteria, and could provide a target for developing new antibiotics.

READ MORE

Reference: “Dynamic competition between a ligand and transcription factor NusA governs riboswitch-mediated transcription regulation,” Adrien ChauvierPujan Ajmera, Rajeev Yadav, and  Nils G. Walter, Proceedings of the National Academy of Sciences,

Similar Posts

  • Michigan Medicine Health Lab features CRB faculty work with biomarkers

    Research Update: Sunitha Nagrath and Muneesh Tewari. CRB Faculty Members Sunitha Nagrath, Ph.D., and Muneesh Tewari, Ph.D., M.D., are learning the potential that liquid biopsies hold as a potential non-invasive, diagnostic tool. Their research is cited in a new article recently published in Health Lab. Dr. Nagrath reveals that circulating biomarkers found in bodily fluids…

  • MCubed Block – the foundation that would lead to the Center for RNA Biomedicine

    MCubed stimulates innovative research and scholarship by distributing real-time seed funding to multi-unit, faculty-led teams.  Through this revolutionary research funding program, faculty from at least two different campus units can form a collaborative trio, or “cube,” and request either $60K or $15K to advance their idea right away. The projects below represent RNA-related science developed as…

  • |

    miR-181a, a microRNA that regulates ovarian cancer cells

    by Elisabeth Paymal One of the hallmarks of ovarian cancer is genomic instability resulting in gain and loss of DNA throughout the entire genome, including many microRNAs (miRNA). Dr. DiFeo, Ph.D., Associate Professor of Pathology and of Obstetrics and Gynecology at Michigan Medicine, and her team, research which miRNAs are involved in the early stages…

  • 2020-2021 Seminars

    Read about our 2020-21 Seminar season here. Monday, June 14, 4:00 pm, Yousuf Khan, Stanford and Mike McMillan, University of Michigan – Link to recording Monday, May 17, 4:00 pm, Thomas Martinez, Salk Institute for Biological Studies Monday, May 3, 4:00 pm, Olivia Rissland, University of Colorado, Medical School Monday, April 19, 4:00 pm, Jailson…

  • RNA Translated 2024 is out in wide release!

    The latest issue of RNA Translated, the University of Michigan Center for RNA Biomedicine annual magazine and brief report, has been published and is available in print and to view online now!   The 2024 issue focuses on our groundbreaking efforts to build a University of Michigan “M-RNA Therapeutics” initiative, led by Michelle Hastings, Ph.D.,…

  • Exploring unknown territories

    Chase Weidmann had three goals for a career: do something “cool,” improve the lives of other people, and, of course, be able to support himself. Weidmann found the “cool” in high school science classes and he quickly realized that biology and `biotechnology offer vast uncharted territories to explore. One such uncharted area was the academic…